Alleima AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

Alleima AB (publ) (STO:ALLEI) just released its quarterly report and things are looking bullish. The company beat forecasts, with revenue of kr5.2b, some 7.8% above estimates, and statutory earnings per share (EPS) coming in at kr1.57, 26% ahead of expectations. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Taking into account the latest results, the five analysts covering Alleima provided consensus estimates of kr19.6b revenue in 2025, which would reflect a noticeable 2.6% decline over the past 12 months. Statutory earnings per share are forecast to dip 4.8% to kr5.95 in the same period. In the lead-up to this report, the analysts had been modelling revenues of kr19.6b and earnings per share (EPS) of kr6.62 in 2025. So there's definitely been a decline in sentiment after the latest results, noting the real cut to new EPS forecasts.

See our latest analysis for Alleima

The consensus price target held steady at kr93.00, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Alleima analyst has a price target of kr110 per share, while the most pessimistic values it at kr75.00. These price targets show that analysts do have some differing views on the business, but the estimates do not vary enough to suggest to us that some are betting on wild success or utter failure.

Another way we can view these estimates is in the context of the bigger picture, such as how the forecasts stack up against past performance, and whether forecasts are more or less bullish relative to other companies in the industry. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 3.5% by the end of 2025. This indicates a significant reduction from annual growth of 7.5% over the last three years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 4.9% per year. It's pretty clear that Alleima's revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Alleima's revenue is expected to perform worse than the wider industry. The consensus price target held steady at kr93.00, with the latest estimates not enough to have an impact on their price targets.

With that in mind, we wouldn't be too quick to come to a conclusion on Alleima. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for Alleima going out to 2027, and you can see them free on our platform here..

Another thing to consider is whether management and directors have been buying or selling stock recently. We provide an overview of all open market stock trades for the last twelve months on our platform, here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.